TARGET – Long-term benefit of allergen-specific immunotherapy with MCT-associated pollen SCIT allergoids on asthma in children and adolescents under real life conditions
Vogelberg C., Klimek L.,Kruppert S., Becker S.
EAACI Hybrid Congress 2022. E-Poster 296.